Various abnormalities of hemostasis have been described in obesity, mainly concerning increased levels of plasminogen activator inhibitor-1, but other abnormalities of coagulation and platelet activation have been reported as well. Circulating microparticles have also been observed in obese patients. These suggest that obesity would be a risk factor for venous thromboembolism (VTE). Analysis of...

BACKGROUND Cancer is associated with an increased risk of thromboembolic diseases, but data on the association between prostate cancer and thromboembolic diseases are scarce. We investigated the risk of thromboembolic disease in men with prostate cancer who were receiving endocrine treatment, curative treatment, or surveillance. METHODS We analysed data from PCBaSe Sweden, a database based on...

SA@ETAK. Fatalna plu}na embolija u mnogim razvijenim zemljama ostaje najva`niji uzrok mortaliteta u trudno}i, a za povi{enu incidenciju tromboembolijskih incidenata u trudno}i znamo ve} stolje}ima. Fiziolo{ka zbivanja u trudno}i dovode do stanja hiperkoagulabilnosti, {to povisuje rizik za venski tromboembolizam (VTE). @ene s priro|enim ili ste~enim trombofilijama imaju za vrijeme trudno}e poseb...

Venous thromboembolic disease is a major cause of morbidity and mortality worldwide and is comprised of two main conditions: deep vein thrombosis (DVT) and pulmonary embolism (PE). Its exact incidence is uncertain, but the incidence of first time venous thromboembolism (VTE) in the United States is estimated at approximately 100 persons per 100, 000 each year. Multiple factors result in increas...

OBJECTIVES To measure the D-dimer concentrations in both healthy dogs and dogs with and without evidence of thromboembolic disease/disseminated intravascular coagulation using a "Point-of-Care" test. METHODS Sixty-seven clinical cases and 26 healthy dogs were included in this retrospective study. D-dimer was measured using the NycoCard D-dimer test. Clinical conditions were categorised based ...